HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vaccine against autoimmune disease: antigen-specific immunotherapy.

Abstract
Recent interest in testing whether the success of antigen-specific immunotherapy (ASIT) for autoimmune diseases in mice can be translated to humans has highlighted the need for better tools to study and understand human autoimmunity. Clinical development of ASIT for allergy has been instructive, but limited understanding of CD4 T cell epitope/determinant hierarchies hampers the rational design and monitoring of ASIT. Definitive identification of pathogenic T cell epitopes as is now known in celiac disease and recent initiatives to optimize immune monitoring will facilitate rational design, monitoring and mechanistic understanding of ASIT for human autoimmune diseases.
AuthorsRobert P Anderson, Bana Jabri
JournalCurrent opinion in immunology (Curr Opin Immunol) Vol. 25 Issue 3 Pg. 410-7 (Jun 2013) ISSN: 1879-0372 [Electronic] England
PMID23478068 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2013 Elsevier Ltd. All rights reserved.
Chemical References
  • Antigens
  • Vaccines
Topics
  • Animals
  • Antigens (immunology)
  • Autoimmune Diseases (immunology, therapy)
  • Celiac Disease (immunology)
  • Humans
  • Hypersensitivity (immunology)
  • Immunotherapy
  • Vaccines (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: